ATE441702T1 - Verfahren zur herstellung eines hmg-coa reduktase hemmers - Google Patents

Verfahren zur herstellung eines hmg-coa reduktase hemmers

Info

Publication number
ATE441702T1
ATE441702T1 AT00901980T AT00901980T ATE441702T1 AT E441702 T1 ATE441702 T1 AT E441702T1 AT 00901980 T AT00901980 T AT 00901980T AT 00901980 T AT00901980 T AT 00901980T AT E441702 T1 ATE441702 T1 AT E441702T1
Authority
AT
Austria
Prior art keywords
substituted
hmg
producing
coa reductase
reductase inhibitor
Prior art date
Application number
AT00901980T
Other languages
English (en)
Inventor
Hirofumi Endo
Yoshiyuki Yonetani
Hiroshi Mizoguchi
Shin-Ichi Hashimoto
Akio Ozaki
Original Assignee
Kyowa Hakko Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Bio Co Ltd filed Critical Kyowa Hakko Bio Co Ltd
Application granted granted Critical
Publication of ATE441702T1 publication Critical patent/ATE441702T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
AT00901980T 1999-01-29 2000-01-28 Verfahren zur herstellung eines hmg-coa reduktase hemmers ATE441702T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2170799 1999-01-29
PCT/JP2000/000472 WO2000044886A1 (fr) 1999-01-29 2000-01-28 TECHNIQUE DE PRODUCTION D'INHIBITEUR DE HMG-CoA REDUCTASE

Publications (1)

Publication Number Publication Date
ATE441702T1 true ATE441702T1 (de) 2009-09-15

Family

ID=12062541

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00901980T ATE441702T1 (de) 1999-01-29 2000-01-28 Verfahren zur herstellung eines hmg-coa reduktase hemmers

Country Status (14)

Country Link
US (4) US7049111B1 (de)
EP (1) EP1148122B1 (de)
JP (1) JP4668420B2 (de)
KR (1) KR20010108139A (de)
CN (1) CN1329508C (de)
AT (1) ATE441702T1 (de)
AU (1) AU2321600A (de)
CA (1) CA2360080A1 (de)
CZ (1) CZ20012728A3 (de)
DE (1) DE60042879D1 (de)
HK (1) HK1040530A1 (de)
HU (1) HUP0105145A3 (de)
IL (1) IL144526A0 (de)
WO (1) WO2000044886A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4428866B2 (ja) 1999-01-20 2010-03-10 協和発酵バイオ株式会社 HMG−CoAレダクターゼ阻害剤の製造法
KR20010108139A (ko) 1999-01-29 2001-12-07 히라타 다다시 히드록시메틸글루타릴 코에이 환원효소 저해제의 제조방법
JP5631534B2 (ja) * 2005-11-29 2014-11-26 協和発酵バイオ株式会社 新規蛋白質および該蛋白質をコードするdna
JP2010512733A (ja) * 2006-12-13 2010-04-30 ディーエスエム アイピー アセッツ ビー.ブイ. プラバスタチンを調製するための方法
US8383381B2 (en) 2007-09-27 2013-02-26 Shjonogi & Co., Ltd. Method for producing hydroxylated adaivjantane using cytochrome P450

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149080C (da) 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5750894A (en) 1980-09-08 1982-03-25 Sankyo Co Ltd Preparation of ml-236b derivative
JPS5720894A (en) 1980-07-15 1982-02-03 Nippon Keibi Hosho Kk Fault diagnozing method for ultrasonic alarm unit
US4356621A (en) 1980-07-25 1982-11-02 Toyoda Koki Kabushiki Kaisha Machine tool with automatic tool change
JPS5889191A (ja) 1981-11-20 1983-05-27 Sankyo Co Ltd 3−ヒドロキシ−ml−236b誘導体の製造法
JP2672551B2 (ja) * 1987-03-02 1997-11-05 三共株式会社 チトクロームp−450遺伝子を含有するdna
US6043064A (en) * 1993-10-22 2000-03-28 Bristol-Myers Squibb Company Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof
US5942423A (en) 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
AU8460698A (en) * 1997-08-07 1999-03-01 Kyowa Hakko Kogyo Co. Ltd. Process for the preparation of hmg-coa reductase inhibitors
EP1015600A1 (de) 1997-08-22 2000-07-05 Dsm N.V. Fermentative herstellung von statin
SI9800144A (sl) 1998-05-21 1999-12-31 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Nov biotehnološki postopek pridobivanja 3-hidroksi-ML-236B derivatov poznanih kot M-4 in M-4'
JP4428866B2 (ja) 1999-01-20 2010-03-10 協和発酵バイオ株式会社 HMG−CoAレダクターゼ阻害剤の製造法
KR20010108139A (ko) 1999-01-29 2001-12-07 히라타 다다시 히드록시메틸글루타릴 코에이 환원효소 저해제의 제조방법

Also Published As

Publication number Publication date
AU2321600A (en) 2000-08-18
KR20010108139A (ko) 2001-12-07
EP1148122B1 (de) 2009-09-02
US20090148916A1 (en) 2009-06-11
US20060154348A1 (en) 2006-07-13
US7897370B2 (en) 2011-03-01
CA2360080A1 (en) 2000-08-03
CN1345371A (zh) 2002-04-17
US7049111B1 (en) 2006-05-23
HUP0105145A3 (en) 2006-02-28
CZ20012728A3 (cs) 2002-02-13
EP1148122A4 (de) 2008-02-13
WO2000044886A1 (fr) 2000-08-03
IL144526A0 (en) 2002-05-23
EP1148122A1 (de) 2001-10-24
HK1040530A1 (zh) 2002-06-14
DE60042879D1 (de) 2009-10-15
CN1329508C (zh) 2007-08-01
US7470528B2 (en) 2008-12-30
US20080261273A1 (en) 2008-10-23
HUP0105145A2 (hu) 2002-04-29
JP4668420B2 (ja) 2011-04-13

Similar Documents

Publication Publication Date Title
NO20062656L (no) Fremgangsmate for fremstilling av statiner
AU2001252595A1 (en) Process for producing optically active sulfoxide derivative
DE69706366D1 (de) Verfahren zur Herstellung von Paroxetine
HUP0204347A2 (en) Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them and their use
ATE441702T1 (de) Verfahren zur herstellung eines hmg-coa reduktase hemmers
DE60309251D1 (de) Verfahren zur Herstellung von Donepezil
HUP0401600A2 (hu) Eljárás 14-hidroximorfin-származékok előállítására
BR0115870A (pt) Processos de acoplamento e intermediários úteis para preparação de cefalosporinas
DE60022416D1 (de) Verfahren zur Herstellung von 2-Alkyl-3-aminothiophen Derivate und 3-Aminothiophen Derivate
AU2002228057A1 (en) Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
AU4663301A (en) Method for preparing (2S,3R,4S)-4-hydroxyisoleucine and analogues thereof
ATE223414T1 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
ATE360703T1 (de) Verfahren zur herstellung von hemmern der hmg-coa reduktase
DE69839248D1 (de) VERFAHREN FÜR DIE HERSTELLUNG VON INHIBITOREN DER HMG-CoA-REDUKTASE.
ES2144327T3 (es) Procedimiento para preparar un compuesto de 2-cianobifenilo.
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
PL354677A1 (en) A process for the preparation of {2-[4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy}acetic acid and novel intermediates therefor
WO2001025215A3 (de) Verfahren zur selektiven spaltung cyclischer carbonsäureanhydride
ATE319722T1 (de) Verfahren zur herstellung von vitamin-d analogen
EP1445262A4 (de) Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung
EP0934936A4 (de) Oxazolidinverbindungen und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties